Skip to main content
. 2018 Jun;10(6):3319–3328. doi: 10.21037/jtd.2018.05.96

Table 3. Univariate and multivariate analysis of the risk factors for non-invasive ventilation failure.

Variable No. of patients with failures/total (%) Univariate analysis Multivariate analysis AUC
OR 95% CI OR 95% CI AUC 95% CI
BMI, kg/m2
   <25 34/69 (49.3) 1.00 1.00 0.642 0.538–0.745
   ≥25 9/43 (20.9) 0.27 0.11–0.65 0.21 0.07–0.65
Underlying disease
   None of the following 26/49 (53.1) 1.00
   Hypertension 17/63 (27.0) 0.33 0.15–0.72
Etiology of respiratory failure
   None of the following 25/85 (29.4) 1.00 1.00 0.644 0.535–0.753
   Pneumonia 18/27 (66.7) 4.80 1.90–12.12 6.40 2.08–19.71
Type of surgery
   None of the following 38/87 (43.7) 1.00
   Aorta surgery 5/25 (20.0) 0.32 0.11–0.94
Blood transfusion
   No 18/67 (26.9) 1.00
   Yes 25/45 (55.6) 3.40 1.53–7.56
Low cardiac output syndrome
   No 22/77 (28.6) 1.00
   Yes 21/35 (60.0) 3.68 1.59–8.52
Renal failure before NIV
   No 26/82 (31.7) 1.00
   Yes 17/29 (58.6) 3.11 1.29–7.42
Bilirubin, µmol/L
   <34 19/68 (27.9) 1.00
   ≥34 24/44 (54.5) 3.10 1.40–6.86
PLT before NIV, ×109/L
   >130 5/32 (15.6) 1.00
   ≤130 38/80 (47.5) 4.80 1.71–13.97
Vasoactive-inotropic score before NIV
   <6 11/53 (20.8) 1.00 1.00 0.676 0.574–0.778
   ≥6 32/59 (54.2) 4.52 1.96–10.47 3.31 1.22–8.98
SOFA score before NIV
   <10.5 28/88 (31.8) 1.00 1.00 0.666 0.557–0.774
   ≥10.5 15/24 (62.5) 7.56 2.69–21.25 6.81 2.06–22.46
Total 0.830 0.752–0.907

AUC, area under the curve; BMI, body mass index; CI, confidence interval; NIV, non-invasive ventilation; OR, odds ratio; PLT, platelet count; SOFA, Sequential Organ Failure Assessment. Vasoactive-inotropic score: dosages of dopamine + dobutamine (ìg/kg/min) + [dosages of epinephrine + norepinephrine + isoproterenol (ìg/kg/min)] ×100 + dosages of milrinone (ìg/kg/min) ×15.